journal article·2022-03-02Open access

Successful Second Autologous Stem Cell Transplantation for Late Disease Progression after the First Procedure in POEMS Syndrome

Francesco Autore, Idanna Innocenti, Federica Sora, Patrizia Chiusolo, Nicola Piccirillo, Andrea Bacigalupo, Simona Sica, Luca Laurenti

Applied Sciences· Volume 12· Issue 5

Abstract

Autologous stem cell transplantation (ASCT) is a good option in fit young patients affected by POEMS syndrome. Few data are published on how to treat these patients in case of relapse. In this paper we described our two patients who underwent a second ASCT. From our experience, we can confirm that a second transplant is a real treatment option with good results and limited side effects. It provided excellent response and long-term disease-free survival in POEMS patients who relapsed after a first transplant, including late relapses.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peripheral Neuropathies and Disorders · Hereditary Neurological Disorders · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy

Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy

References (17)

Show source-provided references
1. POEMS syndrome: 2011 update on diagnosis, risk-stratification and management10.1002/ajh.22050 ↗
2. POEMS syndrome: Definitions and long-term outcome10.1182/blood-2002-07-2299 ↗
3. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome10.1182/blood.V99.8.3057 ↗
4. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature10.1182/blood-2004-05-2046 ↗
5. Early diagnosis followed by frontline autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome10.1016/j.leukres.2007.11.029 ↗
6. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation10.3324/haematol.2016.148460 ↗
7. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome10.1182/blood-2010-12-328112 ↗
8. POEMS syndrome with severe neurological damage clinically recovered with lenalidomide10.3324/haematol.2011.041897 ↗
9. Bortezomib: A new therapeutic option for POEMS syndrome10.1111/j.1600-0609.2009.01341.x ↗
10. Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome10.1038/s41409-020-01024-9 ↗
11. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome10.1182/blood-2017-07-795385 ↗
12. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): A singlecenter experience10.1182/blood-2012-04-423178 ↗
13. Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome10.1038/leu.2017.27 ↗
14. Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilizationin POEMS syndrome: A case series with cytokine analysis10.1016/j.transci.2015.10.016 ↗
15. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome10.1002/hon.2478 ↗
16. Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor10.1038/bmt.2012.80 ↗
17. Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers10.1016/j.bbmt.2019.08.011 ↗